News Home

Where Does Caribou Biosciences Inc (CRBU) Stock Fall in the Biotechnology Field After It Is Down -3.21% This Week?

Tuesday, October 19, 2021 02:47 PM | InvestorsObserver Analysts
Where Does Caribou Biosciences Inc (CRBU) Stock Fall in the Biotechnology Field After It Is Down -3.21% This Week?

Caribou Biosciences Inc (CRBU) is near the middle in its industry group according to InvestorsObserver. CRBU gets an overall rating of 38. That means it scores higher than 38 percent of stocks. Caribou Biosciences Inc gets a 46 rank in the Biotechnology industry. Biotechnology is number 87 out of 148 industries.

Overall Score - 38
CRBU has an Overall Score of 38. Find out what this means to you and get the rest of the rankings on CRBU!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Caribou Biosciences Inc Stock Today?

Caribou Biosciences Inc (CRBU) stock is trading at $19.87 as of 2:44 PM on Tuesday, Oct 19, a loss of -$0.16, or -0.8% from the previous closing price of $20.03. The stock has traded between $19.76 and $20.91 so far today. Volume today is less active than usual. So far 289,149 shares have traded compared to average volume of 767,944 shares. Click Here to get the full Stock Report for Caribou Biosciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App